• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of immunoproteins in the survival of liposomes in the circulation.

作者信息

Devine D V, Marjan J M

机构信息

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

出版信息

Crit Rev Ther Drug Carrier Syst. 1997;14(2):105-31.

PMID:9107519
Abstract

The clearance of liposomes from the circulation is mediated largely by the cells of the reticuloendothelial system. These cells recognize liposome-bound immunoproteins, particularly immunoglobulins and complement. This review addresses the state of knowledge of the plasma proteins that can initiate complement activation and antibody binding and the known interactions among these proteins and liposomes. Evidence for the involvement of immunoproteins and other molecules in the in vivo survival of liposomes is also reviewed.

摘要

相似文献

1
The role of immunoproteins in the survival of liposomes in the circulation.
Crit Rev Ther Drug Carrier Syst. 1997;14(2):105-31.
2
Serum opsonins and liposomes: their interaction and opsonophagocytosis.血清调理素与脂质体:它们的相互作用及调理吞噬作用。
Crit Rev Ther Drug Carrier Syst. 1992;9(1):39-90.
3
The interaction of liposomes with the complement system.脂质体与补体系统的相互作用。
Crit Rev Ther Drug Carrier Syst. 1998;15(1):57-88.
4
[The complement system as a mediator of acute inflammation].[补体系统作为急性炎症的介质]
Dtsch Tierarztl Wochenschr. 1983 Sep 8;90(9):374-7.
5
[Complement enables the physiological elimination of immune complexes].补体可促使免疫复合物进行生理性清除。
Ther Umsch. 1988 Feb;45(2):74-8.
6
Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.多次注射后聚乙二醇化脂质体的血液清除加速:阿霉素包封及高剂量首次注射的影响
J Control Release. 2006 Oct 27;115(3):251-8. doi: 10.1016/j.jconrel.2006.08.017. Epub 2006 Sep 3.
7
In vivo studies on the role of complement in the clearance of liposomes in rats and guinea pigs.
Biol Pharm Bull. 1999 May;22(5):515-20. doi: 10.1248/bpb.22.515.
8
Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma.羧基荧光素在人血浆中从十六烷基甘露糖苷修饰脂质体的尺寸依赖性释放。
Biopharm Drug Dispos. 1996 Mar;17(2):145-54. doi: 10.1002/(SICI)1099-081X(199603)17:2<145::AID-BDD942>3.0.CO;2-Y.
9
Poly(amino acid)s: promising enzymatically degradable stealth coatings for liposomes.聚氨基酸:用于脂质体的有前景的酶促可降解隐形涂层。
Int J Pharm. 2007 Mar 1;331(2):186-9. doi: 10.1016/j.ijpharm.2006.11.018. Epub 2006 Nov 11.
10
Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.脾脏在聚乙二醇化脂质体加速血液清除的诱导过程中发挥着重要作用。
J Control Release. 2006 Oct 27;115(3):243-50. doi: 10.1016/j.jconrel.2006.08.001. Epub 2006 Aug 7.

引用本文的文献

1
PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study.聚乙二醇化与非聚乙二醇化pH敏感脂质体:一项对比抗肿瘤活性研究的新见解
Pharmaceutics. 2022 Jan 24;14(2):272. doi: 10.3390/pharmaceutics14020272.
2
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.纳米颗粒诱导的补体激活:对癌症纳米医学的启示。
Front Immunol. 2021 Jan 8;11:603039. doi: 10.3389/fimmu.2020.603039. eCollection 2020.
3
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.
脂质体两性霉素 B 的临床前安全性、耐受性、药代动力学、药效学和抗真菌活性。
Clin Infect Dis. 2019 May 2;68(Suppl 4):S244-S259. doi: 10.1093/cid/ciz064.
4
Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.药物传递系统的药代动力学和药效学特性。
J Pharmacol Exp Ther. 2019 Sep;370(3):570-580. doi: 10.1124/jpet.119.257113. Epub 2019 Mar 5.
5
Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes.聚乙二醇(PEG)涂层对 pH 敏感脂质体的生物分布和肿瘤蓄积的影响。
Drug Deliv Transl Res. 2019 Feb;9(1):123-130. doi: 10.1007/s13346-018-0583-8.
6
Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.药代动力学和药效学分析在肿瘤脂质体制剂开发中的应用。
Pharmaceutics. 2014 Mar 18;6(1):137-74. doi: 10.3390/pharmaceutics6010137.
7
Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.磷脂囊泡介导补体成分 C3 的非蛋白水解激活。
Biomaterials. 2014 Apr;35(11):3688-96. doi: 10.1016/j.biomaterials.2013.12.085. Epub 2014 Jan 23.
8
Stability of Self-Assembled Polymeric Micelles in Serum.自组装聚合物胶束在血清中的稳定性
Macromolecules. 2011 Aug 9;44(15):6002-6008. doi: 10.1021/ma200675w. Epub 2011 Jul 8.
9
Immunological risk of injectable drug delivery systems.注射用药物递送系统的免疫风险。
Pharm Res. 2009 Jun;26(6):1303-14. doi: 10.1007/s11095-009-9855-9. Epub 2009 Feb 27.
10
Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.脂质体特性和剂量对聚氨基酸包被脂质体药代动力学的影响。
Pharm Res. 2007 Dec;24(12):2394-401. doi: 10.1007/s11095-007-9393-2. Epub 2007 Aug 3.